Federal judge says plaintiffs “have at best shown that St. Ives Scrub could, in theory, alter the skin’s surface.” Drug and device law attorney says the complaint "is not really a labeling issue” and the court applied “a healthy dose of common sense” in ruling.
A federal judge in California dismissed claims in a putative class action against St. Ives Apricot Scrub, granting Unilever PLC’s motion for summary judgement and quashing an attempt to link the product to potential skin injuries.
Judge Andrew Guilford in the US District Court for the Central District of California granted summary judgement in a Dec....
The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”
US FDA Office of New Drugs Director Peter Stein says review divisions have made the case that a discussion-only meeting would solicit the necessary input.
Requests for “enforcement actions are not within the scope of FDA’s citizen petition procedures,” CDER says, rejecting petition dosing device firm Parenteral Technologies submitted as it prepares for workshop on Pediatric Research Equity Act requirements for OTC NDA sponsors.
